Drawing for RITMITINA

USPTO serial 79115032

RITMITINA

Reviewed by CopyMark Law Group

Reg. 4287404Status 404
Filing date
Status date
Registration date
Feb 12, 2013
Examiner
BUTLER, MIDGE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RITMITINA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

MARTIN J. BERAN

MARTIN J. BERAN OSTROLENK FABER LLP1180 AVENUE OF THE AMERICASNEW YORK, NY 10036-8403UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
041Publication of printed matter and electronic publication in the field of clinical studies involving pharmaceutical preparationsSECTION 71 - CANCELLED—
042Conducting of clinical studies for pharmaceutical preparationsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 4, 2023UNDNUNDELIVERABLE MAIL - NO ACTION TAKEN—
Dec 4, 2022DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Dec 4, 2022DETHDEATH OF INTERNATIONAL REGISTRATION—
Jul 17, 2020INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jun 16, 2020INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jun 16, 2020INPCINVALIDATION PROCESSED—
May 13, 2020INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 13, 2019C71TCANCELLED SECTION 71—
Jul 1, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 7, 2013FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 7, 2013FIMPFINAL DISPOSITION PROCESSED—
May 12, 2013FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 12, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 11, 2012GPNXNOTIFICATION PROCESSED BY IB—
Nov 27, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 7, 2012OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 7, 2012OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 7, 2012NPUBNOTICE OF PUBLICATION—
Oct 25, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 25, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 25, 2012ACECAMENDMENT FROM APPLICANT ENTERED—
Oct 25, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 20, 2012ALIEASSIGNED TO LIE—
Oct 9, 2012MAILPAPER RECEIVED—
Sep 23, 2012RFNTREFUSAL PROCESSED BY IB—
Sep 18, 2012TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 31, 2012RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 31, 2012RFRRREFUSAL PROCESSED BY MPU—
Aug 31, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 30, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 30, 2012DOCKASSIGNED TO EXAMINER—
Aug 7, 2012MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 3, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 2, 2012REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance